New Life Medicals
Dr. Dipankar Dutta currently serves as the Group CEO and Additional Director at New Life Medicals, where responsibilities include overseeing global operations across India, the US, and Ireland since January 2022. Previously, Dr. Dutta was a Lead Consultant at NABARD Consultancy Services, focusing on social transformation initiatives in rural Gujarat, managing campaigns across 16 districts. Additional experience includes strategic roles at EdWINtage, Kenzai, Veberley Bioceutics, Cadila Pharmaceuticals, Emcure Pharmaceuticals, Torrent Pharmaceuticals, Zydus, and Aditiany Inc., with a strong emphasis on marketing, strategy development, and operational leadership within the healthcare sector. Dr. Dutta holds a Doctorate in Management Studies (Digital Marketing) from ISBM University, an MBA from Gauhati University, and various other educational credentials in science and medicine.
This person is not in any teams
This person is not in any offices
New Life Medicals
We started our journey with sourcing and supplying of APIs & Bulk drugs to the local Manufacturers during which New Life Medicals has focused on winning the trust & faith of the clients as per the business Ethics. With an aim to contribute significantly in the Pharmaceutical R&D, we entered in to sourcing and supplying of Reference listed Drugs(RLDs) and Comparator drugs for Clinical Trial Study Across All Therapeutic Segments. Today we have a cluster of satisfied clients and strong Sourcing network of suppliers from US, EU, Canada, Australia, Japan, China, Asia & many more. New Life Medicals is a group of entities present into the United States, India and Ireland having access to the Biosimilars, Orphan drugs, REMS, Complex products and molecules from global markets for the supplies into the clinical trials, & Name patient Drugs. New Life Medicals also has its own manuf. capabilities of the Finished formulations. New Life Medicals is having the foot prints into the various countries across the globe full time wholesaler as exporter and with its own generic products ( white labelled products ) offering the MA and exclusive strategic partnership with various stakeholders.